Operating Lease, Right-of-Use Asset of LIFECORE BIOMEDICAL, INC. \DE\ from 26 May 2019 to 23 Feb 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
LIFECORE BIOMEDICAL, INC. \DE\ quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 26 May 2019 to 23 Feb 2025.
  • LIFECORE BIOMEDICAL, INC. \DE\ Operating Lease, Right-of-Use Asset for the quarter ending 23 Feb 2025 was $2,233,000, a 11% decline year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

LIFECORE BIOMEDICAL, INC. \DE\ Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q1 2025 $2,233,000 -$277,000 -11% 23 Feb 2025 10-Q 03 Apr 2025 2025 Q3
Q4 2024 $2,304,000 -$1,732,000 -43% 24 Nov 2024 10-Q 02 Jan 2025 2025 Q2
Q3 2024 $2,373,000 -$1,786,000 -43% 25 Aug 2024 10-Q 04 Oct 2024 2025 Q1
Q2 2024 $2,442,000 -$1,840,000 -43% 26 May 2024 10-Q 03 Apr 2025 2025 Q3
Q1 2024 $2,510,000 -$2,590,000 -51% 25 Feb 2024 10-Q 09 Aug 2024 2024 Q3
Q4 2023 $4,036,000 -$1,215,000 -23% 26 Nov 2023 10-Q 09 Aug 2024 2024 Q2
Q3 2023 $4,159,000 -$1,237,000 -23% 27 Aug 2023 10-Q 09 Aug 2024 2024 Q1
Q2 2023 $4,282,000 -$1,271,000 -23% 28 May 2023 10-K 26 Aug 2024 2024 FY
Q1 2023 $5,100,000 -$603,000 -11% 26 Feb 2023 10-K 20 Mar 2024 2023 FY
Q4 2022 $5,251,000 -$2,236,000 -30% 27 Nov 2022 10-K 20 Mar 2024 2023 FY
Q3 2022 $5,396,000 -$2,300,000 -30% 28 Aug 2022 10-K 20 Mar 2024 2023 FY
Q2 2022 $5,553,000 -$7,983,000 -59% 29 May 2022 10-K 20 Mar 2024 2023 FY
Q1 2022 $5,703,000 -$9,700,000 -63% 27 Feb 2022 10-K 20 Mar 2024 2023 FY
Q4 2021 $7,487,000 -$5,204,000 -41% 28 Nov 2021 10-K 20 Mar 2024 2023 FY
Q3 2021 $7,696,000 -$5,663,000 -42% 29 Aug 2021 10-K 20 Mar 2024 2023 FY
Q2 2021 $13,536,000 -$11,785,000 -47% 30 May 2021 10-K 20 Mar 2024 2023 FY
Q1 2021 $15,403,000 -$9,784,000 -39% 28 Feb 2021 10-K 20 Mar 2024 2023 FY
Q4 2020 $12,691,000 -$17,088,000 -57% 29 Nov 2020 10-K 20 Mar 2024 2023 FY
Q3 2020 $13,359,000 -$15,367,000 -53% 30 Aug 2020 10-K 20 Mar 2024 2023 FY
Q2 2020 $25,321,000 +$25,321,000 31 May 2020 10-K 29 Jul 2021 2021 FY
Q1 2020 $25,187,000 23 Feb 2020 10-Q 03 Apr 2020 2020 Q3
Q4 2019 $29,779,000 24 Nov 2019 10-Q 02 Jan 2020 2020 Q2
Q3 2019 $28,726,000 25 Aug 2019 10-Q 03 Oct 2019 2020 Q1
Q2 2019 $0 26 May 2019 10-K 14 Aug 2020 2020 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.